News | July 27, 2025
Dr. Reddy’s infuses Rs. 565 crore in its Russian subsidiary
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Subscribe To Our Newsletter & Stay Updated
